Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to cause pain or visible symptoms of illness. Several months from now, or perhaps ...

ntu.edu.sg Objective Therapy-induced tumour microenvironment (TME) remodelling poses a major hurdle for cancer cure. As the majority of patients with hepatocellular carcinoma (HCC) exhibits primary or ...

State Key Laboratory of Synthetic Biology, Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), School of Chemical Engineering and Technology, Tianjin ...

The cancer vaccine ... can create a lysate, possibly even tumors of unknown origin, without having to select mRNA sequences, and then adding another component – called AHPC – that helps channel the ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space. View Full Profile. Learn about our Editorial Policies. Physicians may use precision medicine in ...

Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space.

Every cancer genome is unique, resulting in potentially near infinite cancer cell phenotypes and an inability to predict clinical outcomes in most cases. Despite this profound genomic heterogeneity, ...

A spontaneous regression occurs between 2 and 4 months after birth, corresponding to a complete disappearance of tumors ... of B cells, NK, NKT, γδ T cells, CD4, and CD8 T cells (11, 17, 18).